Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **physiological tear film** is a thin fluid layer that coats the ocular surface, primarily the cornea and conjunctiva. It consists of three main layers: - **Lipid layer**: Outermost layer produced by meibomian glands; reduces evaporation. - **Aqueous layer**: Middle layer secreted by lacrimal glands; contains water, electrolytes (Na+, K+, Cl-, Ca2+, Mg2+), proteins (albumin, lysozyme, lactoferrin), growth factors, immunoglobulins (mainly secretory IgA), vitamins, antimicrobials, hormones.[1][2] - **Mucin layer**: Innermost layer produced mainly by conjunctival goblet cells; provides wettability and stability to the ocular surface.[2] The tear film serves several essential functions including lubrication of the eyelids over the globe during blinking,[1] protection against pathogens through antimicrobial proteins like lysozyme and lactoferrin,[2] supply of nutrients such as glucose and electrolytes to avascular corneal tissue,[1] removal of metabolic waste products,[1] scavenging free radicals via antioxidants like vitamin C,[1] immune defense via immunoglobulins such as sIgA,[2] promotion of wound healing through growth factors like epidermal growth factor,[1] and maintenance of optical clarity. Disruption in any component can lead to dry eye disease or other ocular surface pathologies. The physiological tear film itself is *not* considered a therapeutic target in the sense used for receptors or enzymes—it is an anatomical/functional structure rather than a discrete molecular entity suitable for targeted pharmacologic intervention.[3] Therefore, — The entry "Physiological tear film" does *not* correspond to a canonical drug target molecule/receptor. — It should be flagged as incorrect if included in lists intended only for molecular targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological tear film.